In this study, we examined the expression and functions of serum amyloid A (SAA) isoforms during apoptosis of HC11 mammary gland epithelial cells. Expression of SAA mRNAs and apoptosis were increased in HC11 cells by serum withdrawal and gradually decreased upon the addition of serum, or epidermal growth factor (EGF). TNF treatment of HC11 cells also induced expression of SAA genes, and the effect on SAA1 and SAA2 expression was suppressed by treatment with MG132, and in cells transfected with a dominant negative mutant form of IB. Similar results were observed in response to interleukin-1 (IL-1), IL-6 and interferon (IFN). Furthermore, overexpression of the SAA1 and SAA2 isoforms suppressed growth and accelerated apoptosis of HC11 cells by increasing caspase 3/7 and caspase 8 activities, but the apoptotic effect of tumor necrosis factor (TNF) on HC11 cells was not enhanced. We found that expression of SAA1 and SAA2, but not SAA3, was regulated by an NFBdependent pathway, and that overexpression of SAA isoforms accelerated the apoptosis of HC11 cells.
In this study, we examined the expression and functions of serum amyloid A (SAA) isoforms during apoptosis of HC11 mammary gland epithelial cells. Expression of SAA mRNAs and apoptosis were increased in HC11 cells by serum withdrawal and gradually decreased upon the addition of serum, or epidermal growth factor (EGF). TNF treatment of HC11 cells also induced expression of SAA genes, and the effect on SAA1 and SAA2 expression was suppressed by treatment with MG132, and in cells transfected with a dominant negative mutant form of IB. Similar results were observed in response to interleukin-1 (IL-1), IL-6 and interferon (IFN). Furthermore, overexpression of the SAA1 and SAA2 isoforms suppressed growth and accelerated apoptosis of HC11 cells by increasing caspase 3/7 and caspase 8 activities, but the apoptotic effect of tumor necrosis factor (TNF) on HC11 cells was not enhanced. We found that expression of SAA1 and SAA2, but not SAA3, was regulated by an NFBdependent pathway, and that overexpression of SAA isoforms accelerated the apoptosis of HC11 cells.
Key words: serum amyloid A; apoptosis; cytokines; NFB; mammary epithelial cell After completion of lactation, the mammary gland undergoes involution, regressing to a state resembling that of a virgin animal. 1) This phase of mammary gland development is characterized by epithelial cell death and tissue remodeling. 2, 3) Previously, we identified several involution-induced genes, including SAA3, WDNM1, and sulfated glycoprotein-2, in bovine and mouse mammary glands. [4] [5] [6] [7] SAA has been classified into two sub-families: acutephase SAAs (SAA1 and SAA2), which are dramatically up-regulated as acute-phase reactants during inflammation, 8) and constitutive SAA, which is constitutively present in serum and is not significantly increased during inflammation. 9) SAA1 and SAA2 are 95% homologous in both their coding and noncoding regions, and are coordinately induced in response to inflammation. In humans SAA1, 2, and 4 are found during the acute phase liver response in muscle cells, macrophages, and normal tissues. [10] [11] [12] In the mouse, SAA1 and SAA2 are predominantly expressed in the liver, while SAA3 is present in a wide range of extra-hepatic cells and tissues, including macrophages, adipocytes, testis, and spleen. [13] [14] [15] [16] The physiological functions of the SAA family proteins include roles in cholesterol metabolism and transport, inhibition of lymphocyte and endothelial cell proliferation, induction of matrix metalloproteinases, and modulation of the inflammatory response via both antiand pro-inflammatory activities.
TNF, trigger inflammation 25) and stimulate the production of acute-phase proteins, such as c-reactive protein (CRP), SAA, and fibrinogen. 26) Hence SAA is well-characterized as a member of a group of acutephase proteins associated with many inflammatory diseases, but regulation of the expression and functions of extra-hepatic SAA family proteins has not been widely investigated.
In this study, we found that expression of SAA1 and 2, but not of SAA3, is regulated by an NFB-dependent signaling pathway, and that overexpression of SAA genes accelerates the apoptosis of mammary epithelial cells.
Materials and Methods
Cell culture and hormone treatment. The HC11 cell line, a clonal mouse mammary epithelial cell line derived from spontaneously immortalized COMMA1D epithelial cells, [4] [5] [6] was cultured in growth medium at 37 C in 5% CO 2 . The growth medium (GM) consisted of RPMI 1640 (Gibco BRL, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Gibco BRL), 1% glutamine (Gibco BRL), 50 mg/ml gentamycin (Gibco BRL), 5 mg/ml insulin (Sigma, St. Louis, MO), and 10 mg/ml EGF (Sigma). For differentiation, HC11 cells grown to confluence were incubated in differentiation medium (DM: 5 mg/ml insulin, 5 mg/ml prolactin, and 1 mM dexamethasone) for the indicated number of days. The medium was changed every 48 h. Hormone and cytokine treatments were carried out for the indicated times and at the indicated doses.
Transfection of HC11 cells with expression vectors encoding SAA isoforms and IBM. The plasmid pIRES-Neo (Clontech, Palo Alto, CA) and expression vectors encoding SAA1, SAA2, and SAA3 were digested with the restriction enzyme NotI, and the resulting fragments were purified using a QIAEX II gel extraction kit (Qiagen, Hilden, Germany). The SAA1, SAA2, and SAA3 cDNAs were then ligated downstream of the cytomegalovirus (CMV) immediate early promoter of pIRES-Neo. The recombinant plasmids were transformed into XLI-blue E. coli cells, and the correct orientation of the SAA cDNAs in pIRES-Neo was confirmed by digestion with NotI and sequence analysis. To block NFB activation, a constitutively active form of IB, in which serine residues 32 and 36 were replaced with alanines, was purchased from Clontech (pCMV-IBM). For transfection, plasmid DNA was isolated using a Qiagen endo free kit (Qiagen). Cells (3 Â 10 6 ) were seeded in 6-well plates in GM without antibiotics, and the next day they were transfected with recombinant plasmid (4 mg) using lipofectamine 2000 (Gibco BRL), according to the manufacturer's instructions. For the generation of stable cell lines, transfected cells were cultured in selection medium containing 600-1,000 mg/ml Geneticin (G418; Gibco BRL). The medium was changed every 48 h. After 14 d of incubation in G418, single colonies were obtained by trypsinization within a cloning cylinder (Sigma). The cells were transferred into 24-well dishes and cultured in GM containing 1,000 mg/ml of Geneticin. The cells were then transferred onto 6-well dishes for propagation. Genomic DNA was isolated from transfected cells using a Genomic DNA isolation kit (Promega, Madison, Wl), according to the manufacturer's instructions. To confirm the genomic integration of recombinant cDNAs, PCR was performed using isolated genomic DNA as a template and primers specific for the CMV promoter 3 0 end region and the 5 0 end region of the cDNA. PCR was carried out for 35 cycles (preheating at 94 C for 5 min; cycling at 94 C for 1 min 30 s, at 55 C for 1 min 30 s, and at 72 C for 1 min 30 s; final elongation at 72 C for 10 min), and amplified fragments were analyzed by 1.0% agarose gel electrophoresis. Expression of integrated cDNAs in stable transfectants was confirmed by reverse transcriptase (RT)-PCR.
RT-PCR analysis. Total RNA was extracted from mammary gland tissues at various reproductive stages and from HC11 cells using the Trizol reagent (Gibco BRL), according to the manufacturer's instructions. Single-stranded cDNA was synthesized from 3 mg of total cellular RNA using an oligo(dT) primer and reverse transcriptase, as recommended by the manufacturer (Perkin-Elmer/Cetus, Norwalk, CT). Reaction mixtures (20 ml) were prepared as described above. The amplification program consisted of 24-36 cycles of the following parameters: 95 C for 10 s; annealing at 60 C for 30 s, and extension at 72 C for 30 s, followed by a final amplification step of 7 min at 72 C. We confirmed that the levels of the three different PCR targets (SAA1, SAA2, and SAA3) generated by 24-36 PCR cycles were in the linear range. The levels were analyzed and normalized as described previously (data not shown). 27, 28) The slopes of the amplification curves of the RT-PCR products were constant from 24 to 30 cycles, and products were quantified every other cycle in six independent experiments. The amplified products were separated by electrophoresis on a 1.2% agarose gel, visualized with ethidium bromide, and analyzed by Multi-Analyst (Bio-Rad). The steady-state levels of SAA1, SAA2, and SAA3 and the GAPDH mRNAs were quantified and normalized as described above. c-fos and -casein were used as positive controls in cellular proliferation and in differentiation of mammary epithelial cells respectively. The primer sequences used in this study were as follows: SAA1 (accession no., NM009117), sense 5 Cell growth and apoptosis. To determine growth rates, transfected (vector, SAA1, SAA2, and SAA3) and non-transfected HC11 cells were plated in 6-well plastic tissue culture plates at a density of 1 Â 10 5 cells/well. Twelve h after plating, the cells in one plate were incubated in a solution (2 ml/well) containing 0.5% crystal violet and 25% methanol, rinsed with deionized water, dried overnight, and resuspended in 100 ml citrate buffer (0.1 M sodium citrate in 50% ethanol) to assess plating efficiency. The remaining cultures were allowed to grow for an additional 1-4 d before staining. The intensity of crystal violet staining was assessed spectroscopically at a wavelength of 570 nm and quantified using Vmax Kinetic Microplate Reader and Softmax software (Molecular Devices, Menlo Park, CA). To determine apoptosis, cells were seeded in 96-well plates at a density of 1 Â 10 4 cells/well and cultured in GM. On the following day, the cells were incubated in SFM for 12, 24, 36, and 48 h to induce apoptosis. The number of viable cells was measured using Trypan blue. DNA fragmentation analysis was performed as described by Herrman et al., 29) with some modifications. Briefly, genomic DNA was isolated using the Apoptotic DNA ladder kit (Roche, Mannheim, Germany), then subjected to 1% agarose gel electrophoresis to examine fragmentation. To determine the effect of overexpression of SAA isoforms on HC11 cell apoptosis, an Annexin V assay was performed according to the manufacturer's instructions (Annexin V-PE Apoptosis Detection Kit I; BD Biosciences, Palo Alto, CA). Briefly, cells grown in GM were shifted to SFM for 48 h, harvested by trypsinization, and pelleted by centrifugation. Next, 1 Â 10 5 cells in 100 ml of 1Â binding buffer were incubated with Annexin V-PE and 7-aminoactinomycin D, as directed. Flow cytometric analysis (FACStar Plus flow cytometer, Becton-Dickinson, Mountain View, CA) was performed to determine the number of apoptotic cells in each sample.
Caspase activity assays. Caspase 3/7 (Caspase-GLO 3/7 assay kit, Promega, Madison, WI) assays were performed according to the manufacturer's recommendations. 13) Briefly, vector-and SAA-transfected cells (pNeo, SAA1, SAA2, and SAA3, 5 Â 10 3 cells per well) were plated in black 96-well dishes. After 48 h, the fluorescent caspase 3/7 substrate Z-DEVD-R110 was added to each well, and the plates were shaken gently at 500 rpm for 1 min, and then incubated at room temperature in the dark for 2 h. Samples were analyzed using a Xfluor4 Ultra 384 fluorescence plate reader set at 485 nm (excitation)/535 nm (emission). Caspase-8 activity was measured using a Caspase-8 kit (TruPoint Caspase-8 Assay kit, Perkin Elmer) according to the manufacturer's instructions. Briefly, cells were seeded in 100 mm diameter plastic tissue culture dishes and allowed to grow for 2 d. The cells were harvested by trypsinization and pelleted by centrifugation. The following incubation conditions were examined for each cell line: (i) IETD-7-amino-4-trifluoromethyl coumarin (AFC) (fluorescent caspase 8 substrate) alone; (ii) IETD-AFC plus the caspase 8 inhibitor IETD-fmk; and (iii) no substrate. All the samples and a standard curve of fluorescent-free AFC were incubated at 37 C for 2 h. Fluorescence was quantified using an XFluor4 Ultra 384 fluorescence plate reader (Tecan USA, Research Triangle Park, NC) at 405 nm (excitation)/508 nm (emission).
Statistical analysis. Where appropriate, levels of mRNA and protein expression, cell growth, apoptosis, and caspase activity data from in vitro studies were compared by Student's t-test or ANOVA.
Results
First we examined the expression of SAA1, SAA2, and SAA3 mRNAs during mouse mammary gland development and involution by RT-PCR (Fig. 1A) . We observed the highest level of expression of SAA3 mRNA on the 17th day of lactation, and low expression in early involution (day 1 of involution). However, SAA3 mRNA was not expressed during any other period of mammary gland development and involution. The expression patterns of SAA1 and SAA2 mRNAs were similar during mammary gland development and involution, expression first appearing in late pregnancy, reaching a maximum on day 17 of lactation, and then gradually decreasing up to day 4 of involution. These results indicate that SAA isoforms might be involved in the development and/or apoptosis of the mammary gland.
To examine the function of SAA isoforms, HC11 mouse mammary epithelial cells were used as an in vitro model system. [4] [5] [6] HC11 cells were grown to confluence in growth medium (GM) containing 10% FBS and EGF for 2 d, and then cultured in differentiation medium (DM) and/or serum-free medium (SFM). In HC11 cells undergoing differentiation, expression of SAA1, SAA2, and SAA3 mRNAs was induced, and the levels of induction were maintained when the cells were switched to SFM (Fig. 1B and C) . This pattern of SAA1, SAA2, and SAA3 expression was different from the expression pattern of -casein, one of the markers of mammary gland differentiation. During culture in SFM, DNA fragmentation (Fig. 2B ) and a dramatically decreased number of cells ( Fig. 2A) were observed, confirming that the cells were undergoing apoptosis. Induction of SAA1, SAA2, and SAA3 mRNA levels was observed starting at 12 h of culture in SFM, and this high level of expression was maintained throughout the time period examined (Fig. 2C) . SFM-mediated induction of SAA1, SAA2, and SAA3 mRNAs was abrogated by serumstimulation ( Fig. 2D and E) . These results are in agreement with previous data showing that the expression of SAA3 increased during involution of the bovine mammary gland. 30) To determine whether inhibition of apoptosis resulted in down-regulation of SAA1, SAA2, or SAA3 mRNA expression, HC11 cells were treated with EGF, a survival factor.
6) SFM-mediated apoptosis of HC11 cells was abrogated by EGF treatment, as previously observed 6) ( Fig. 3A and F) . These results provided further support for the thesis that the expression of SAA isoform mRNAs is regulated by apoptosis in HC11 cells.
TNF is a pro-inflammatory cytokine that has been found to induce apoptosis in mammary epithelial cells. 31) To determine whether expression of SAA isoform mRNAs was effected by TNF, HC11 cells were treated with increasing doses (0-40 ng/ml) of TNF under SFM conditions. The expression of SAA isoforms was increased by treatment with TNF in a dose-and time-dependent manner ( Fig. 4A-C) . TNF treatment also induced apoptosis of HC11 cells (Fig. 6H) . To determine whether TNF-induced expression of SAA isoform mRNAs was mediated by the nuclear factor (NF)B transcription factor, cells were incubated with carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132), an inhibitor of NFB, with or without TNF, and the expression of SAA mRNAs was examined. Up-regulation of SAA1 and SAA2 expression by TNF was strongly abrogated by MG132 (Fig. 5A) . Expression of SAA3 was partially inhibited by MG132. To confirm this result, we developed stable cell lines overexpressing a constitutively active, dominant negative form of IB (IBM) under the control of the CMV promoter, as well as control cells carrying the empty vector (pCMV). After 2 weeks of selection in G418, integration of plasmid DNA was confirmed by PCR using genomic DNA as the template and CMV5 0 and CMV3 0 primers. Expression of the IB gene was also confirmed by RT-PCR (data not shown). Stable transfectants were grown to confluence in GM, maintained for 2 d in medium containing 2% FBS but lacking insulin and EGF, and then incubated in SFM [4] [5] [6] in the presence or absence of TNF. Similarly to the results of MG132 treatment, up-regulation of SAA1 and SAA2 expression by TNF was abrogated in IB-overexpressing HC11 cells, but not in control cells ( Expression of SAA1, SAA2, and SAA3 mRNAs was analyzed by RT-PCR using total RNA isolated from 6 week-old virgin and early, middle, and late stage pregnant mice (Virgin, EP, MP, and LP respectively) and mice at the indicated days of lactation and involution (A), and total RNA was isolated from cells grown in GM to 70% confluence (GM 70%), in confluent cells cultured in DM for the indicated numbers of days, and in cells cultured in SFM for 48 h after 6 d of differentiation (SFM 48 h) (B). RT-PCR, quantitation of SAA1, SAA2, SAA3, and the loading control GAPDH were performed as described in ''Materials and Methods.'' C, The expression levels of SAA isoform mRNAs were normalized to GAPDH mRNA as compared to the level of expression in GM 70% cells, and were expressed as percent of the GM 70% level. Data represent the means AE standard error for the mean (SE) for duplicate measurements. Three independent experiments were performed and representative data are shown. and C). Also consistently with the effect of MG132 treatment, up-regulation of SAA3 expression by TNF was not changed in IB-overexpressing HC11 cells (Fig. 5B and C) . We expanded this analysis using other cytokines that have been found to induce SAA gene expression in hepatic and non-hepatic cells through the action of NFB. 26) Similarly to TNF, IL-1, IL-6, and IFN also induced the expression of SAA mRNAs. The induction of SAA1 and SAA2 mRNAs by IL-1, IL-6, and IFN was completely inhibited in IB-overexpressing HC11 cells, but not in pCMV-expressing control cells (Fig. 5D) , while the induction of SAA3 expression by IL-1, IL-6, and IFN did not change in IB-overexpressing HC11 cells (Fig. 5D) .
SAA is a member of a group of acute-phase proteins that are associated with many inflammatory diseases, but the function of the SAA proteins has not been fully elucidated. To gain a better understanding of the function of the SAA proteins in the proliferation and apoptosis of mammary epithelial cells, expression vectors encoding SAA1, SAA2, and SAA3 under the control of the CMV promoter were constructed using pCMV-IRES, and then recombinant plasmids were transfected into HC11 cells. Stable cell lines overexpressing SAA1, SAA2, and SAA3, as well as control cells transfected with pNeo, were isolated after 2 weeks of culture in G418 selection medium. We isolated at least 10 colonies from each transfection, and integration of plasmid DNA was confirmed by PCR using genomic DNA and IRES 5 0 and IRES 3 0 primers. Expression of A, HC11 cells were grown to confluence in GM containing EGF, insulin, and FBS, then maintained for 2 d in medium containing 2% FBS and lacking insulin and EGF. The cells were then incubated for 0 to 48 h in SFM. Representative micrographs of the cells after 48 h in GM and SFM are shown. B, Cells were pretreated as described in (A), then incubated for 0 to 48 h in SFM. Genomic DNA was extracted using the Apoptotic DNA Ladder Kit, then analyzed by 1.0% agarose gel electrophoresis. C, Total RNA was extracted from the cells in (B), and RT-PCR analysis of SAA1, SAA2, SAA3 and the loading control GAPDH was carried out as described in ''Materials and Methods.'' D, Cells at 80% confluence in GM were incubated for 24 and 48 h in SFM (SFM day 1 and day 2 respectively), and then the medium was changed to GM for 1-36 h (GM 1 h-GM 36 h). RT-PCR analysis was performed as above, with the addition of c-fos as a positive control for serum responsiveness. E, Expression levels of SAA isoform mRNAs were normalized to GAPDH mRNA, compared to the levels in cells grown in GM, and expressed as fold-change compared to GM samples. The data represent the means AE SE of duplicate measurements. The same experiment was repeated three times, and representative data are shown.
SAA1, SAA2, and SAA3 was confirmed by RT-PCR, and the colonies with the highest levels of expression of each isoform were selected for further experiments (Fig. 6A) . Stable transfectants were cultured in GM, and the growth of each cell line was compared with vectortransfectants (control cells). SAA1-and SAA2-but not SAA3-transfected cells exhibited delayed growth (1:24 AE 0:18, 1:59 AE 0:23, and 2:19 AE 0:21 respectively) as compared to control cells after 4 d (2:32 AE 0:36, Fig. 6B ). The very delayed growth rate of SAA1 and SAA2-transduced HC11 cells indicates a role for SAA isoforms in HC11 proliferation. It was difficult to distinguish, however, whether the growth inhibition induced by overexpression of SAA isoforms that we observed in vitro was due to an effect on cell cycle arrest or rather to apoptosis. Increased apoptosis can lead to a decrease in the measured proliferation rate by increasing cell loss and reducing the number of viable cells produced over time. To determine the mechanism of growth inhibition of the SAA isoforms, we measured apoptosis directly in HC11 cells that overexpressed the SAA isoforms. Cells were cultured in GM as above, then switched to SFM, and cell viability was examined by trypan blue exclusion assay. Cell viability had decreased significantly by 1.4-2.1 fold in SAA1-, SAA2-, and SAA3-transfected cells (36 AE 4%, 35 AE 1%, 53 AE 1:5% respectively) as compared to the control cells (75 AE 4:3%) at 48 h of SFM treatment (Fig. 6C) . Furthermore, DNA fragmentation A, HC11 cells were grown in GM, and the medium was changed to SFM, then cells were treated with or without EGF (50 ng/ml) for 0 to 48 h in SFM. Cell numbers were calculated and normalized to the 0 h time-point (which was set as 100%) B, Representative micrographs of cells after 48 h in SFM and SFM þ EGF. C, RT-PCR analysis of cells treated with the indicated doses of EGF for 48 h in SFM. D, The amplified fragments in (C) were quantified by densitometry, and the SAA/GAPDH value for each sample was normalized to the value at the 0 h time-point, which was set as 1.0. Data are expressed as fold-increase compared to the 0 h level. The data represent the means AE SE of duplicate measurements. The same experiment was repeated three times, and representative data are shown. E, RT-PCR analysis of cells treated with the indicated doses of EGF (50 ng/ml) for 0 to 48 h in SFM. F, The amplified fragments in (E) were quantified and normalized as described for (D). Data represent the means AE SE of triplicate measurements. Three independent experiments were performed, and representative data are shown.
was initially observed in SAA1-, SAA2-, and SAA3-transfected cells after 12 h of incubation in SFM, but was not detected in the control cells (Fig. 6D) . To clarify further the effect of overexpression of SAA isoforms on apoptosis, cells were pretreated as above, and then cultured in SFM, and apoptosis was examined by flow cytometry. Apoptosis was significantly increased by 2.2-3.1 fold in SAA1-, SAA2-, and SAA3-transfected cells (55 AE 4:1%, 41 AE 6:3%, and 45 AE 5:1% respectively) as compared with the control cells (18 AE 2:1%) at 48 h of incubation in SFM (Fig. 6C) . Taken together, these results suggested that overexpression of SAA1 and SAA2 but not of SAA3 leads to delayed HC11 cell growth in GM culture conditions and to accelerated apoptosis under SFM culture conditions, and that SAAs possibly exert their primary effect on apoptotic signaling pathways.
To determine the mechanism by which SAAs stimulate the basal rate of apoptosis in HC11 cells, we examined the activity of several caspases in SAA stable transfectants. First we measured caspase 3/7 basal activity in SAA-transfected cells and control cells by assaying the cleavage of the fluorescence-conjugated caspase 3/7 substrate, ZDEVD-R110. 32 ) Overexpression of SAA1, SAA2, and SAA3 had a significant effect on caspase 3/7 substrate cleavage (4.2-, 3.9-, and 2.5-fold increases respectively) relative to control, vector-transfected cells (Fig. 6F ). When we assayed a different fluorescent substrate specific for caspase 8 (IETD-AFC), we found that this upstream initiator caspase was also affected by SAA expression. Consistently with caspase 3/7 activity, overexpression of SAA1, SAA2, and SAA3 induced strong increases in caspase 8 activity (6.8-, 4.9-, and 2.7-fold increases compared to control respectively; Fig. 6G ). These results imply that the increased basal rate of apoptosis in cells constitutively expressing SAA isoforms was due to activation of caspases in these cells. TNF-induced apoptosis under SFM conditions was not significantly enhanced in SAA1-, SAA2-, or SAA3-transfected cells, compared to the absence of TNF treatment (51 AE 4:9% vs. 55 AE 6:5%, 38:7 AE 2:9% vs. 42 AE 5:9%, and 46:5 AE 5:1% vs. 47:2 AE 4:2% respectively; Fig. 6E ). In contrast, there was a significant increase in apoptosis in vector-transfected control cells in the presence of TNF as compared to treatment with vehicle alone (59:6 AE 4:6% and 19:8 AE 2:1% respectively).
Discussion
SAA proteins are acute-phase proteins expressed primarily in the liver. SAA levels are closely related to the activity of chronic inflammatory diseases, 33) and A, HC11 cells were grown to 80% confluence in GM, the medium was changed to SFM, and the cells were cultured in SFM for 12 h with the indicated doses of TNF (0 to 40 ng/ml). B, HC11 cells were grown in GM, and the medium was changed to SFM with treatment by TNF (20 ng/ml; +) or vehicle (À) for 0 to 48 h. RT-PCR analysis of expression of SAA isoforms and GAPDH was performed using total RNA. C, Amplified fragments of SAA isoforms and GAPDH from (B) were quantified by densitometry, and SAA/GAPDH values were normalized to the 0 h time-point, which was set as 1.0. Data represent the means AE SE of triplicate measurements. Three independent experiments were performed, and representative data are shown.
recently were found to be a predictor of coronary artery disease.
34) The mouse SAA family consists of SAA1, SAA2, and SAA3. SAA1 and SAA2, known as acute-phase SAAs, dramatically increase, by as much as 1,000-fold, during inflammation. SAA3 is classified a constitutive SAA (C-SAA). 35) In the mouse, extra-hepatic synthesis of SAA2 has been definitively documented in the kidney and intestines, while that of SAA1 appears to be restricted to the kidney. 35) SAA3, however, is produced in a wide range of tissues and cell types, including macrophages. 35) Many studies have focused on the regulation of SAA gene expression in liver cells and its putative function as a modulator of acute-phase infection and inflammation. The regulation of expression of SAAs in mammary epithelial cells is less well understood. Previously, SAA3 was identified as a gene that was up-regulated during mammary gland involution. 30, 36) We have found that in high density cell cultures, serum starvation induces apoptosis of HC11 cells. [4] [5] [6] In the current study, we found that the same condition results in elevated expression of SAAs (Fig. 2) . Decreased apoptosis of HC11 cells in SFM culture conditions was observed with the re-addition of serum, or EGF treatment, with a concomitant decrease in the expression of SAAs (Figs. 2-4) . These results indicate that expression of SAA mRNAs is closely related to the apoptosis of HC11 cells.
The pro-inflammatory cytokines IL-1, IL-2, IL-6, IFN, and TNF regulate SAA gene expression in A, HC11 cells were grown in GM, and the medium was changed to SFM, then cells were treated with the indicated doses of TNF-(20 ng/ml) and/or MG132 (dissolved in DMSO), or DMSO alone, in SFM for 18 h. RT-PCR analysis of SAA isoforms and GAPDH was performed as described for B, pCMV-IBM (IB)-or pCMV (pCMV)-transfected cells were grown in GM, and the medium was changed to SFM, then the cells were treated with TNF (20 ng/ml) in SFM for 0 to 48 h. RT-PCR was performed as described for A. C, Amplified fragments of SAA isoforms and GAPDH from (B) were quantified by densitometry and SAAs/GAPDH values were normalized to the 0 h time-point in pCMV cells, which was set as 1.0. Data represent the means AE SE of triplicate measurements. Three independent experiments were performed and representative data are shown. D, Transfected cells pretreated as described for (B) were treated with the indicated cytokines in SFM (TNF-, 20 ng/ml; IL-1, 10 ng/ml; IL-6, 10 ng/ml; IFN, 10 ng/ml) for 24 h. RT-PCR was performed as described for (A).
hepatic and non-hepatic cells, either alone or in various combinations. 37, 38) Evidence is also accumulating that apoptosis induced by these cytokines involves the activation of downstream signaling pathways (i.e., activation of NFB). [39] [40] [41] NFB regulates the transcription of many target genes that are effectors of immune, inflammatory, and acute phase responses. 42) An analysis of the promoters of SAA1 and SAA2 indicated that NFB is essential for cytokine-induced gene expression in HepG2 and Hep3B cells. 43) In agreement with these data, our results indicate that TNF, IL-1, IL-6 and IFN induced expression of SAA mRNAs A, RT-PCR analysis of total RNA from pIRES-Neo (pNeo)-and pIRES-SAA1-, 2-, and 3-transfected cells grown in GM. B, Vector-and SAA1-, SAA2-, and SAA3-transfected cells were grown in GM, and growth rates were determined at the indicated time-points by crystal violet growth assay. The results are expressed as spectrophotometric absorbance at 570 nm, and data represent the means AE SE of triplicate wells; P < 0:01 (Student's t-test). Similar results were observed in three independent experiments. Inset: representative micrographs of each cell line grown in GM for 48 h. C, Cells were grown in GM and then the medium was changed to SFM for 0-48 h. Cell viability was determined by trypan blue assay, and viable cell numbers were normalized to the 0 h time-point, which was set as 100%. D, Genomic DNA was extracted from cells cultured in SFM for 12 h and DNA fragmentation was analyzed. The data are representative of three independent experiments. E, Cells were cultured in GM, and switched to SFM for 48 h, and apoptotic cells were examined by Annexin V assay according to the manufacturer's instructions. F and G, Caspase activity in cells from (E) was measured using cleavage of the fluorescent caspase 3/7 substrate, Z-DEVD-R110 (F), or the caspase 8 substrate, IETD-AFC (G). For caspase 3/7, an experiment was performed, and the results are expressed as relative caspase activity (normalized to that of vector-transfected cells); P < 0:01, Student's t test. For caspase 8, an experiment was carried out, and data are expressed as relative caspase activity (normalized to vector-transfected cells); P < 0:01, Student's t test. H, Cells were cultured in GM, and switched to SFM for 48 h in the absence or presence (20 ng/ml) of TNF, and apoptotic cells were examined by Annexin V assay, as described for (E). Data represent the means AE SE of triplicate measurements. Three independent experiments were performed and representative data are shown.
in mammary epithelial cells. Also, TNF-mediated induction of SAA1 and SAA2 expression, but not of SAA3, was strictly dependent on NFB, since inactivation of NFB by either an NFB-specific inhibitor (MG132) or overexpression of a dominant negative IB mutant abrogated TNF-mediated induction of SAA1 and SAA2 expression. NFB, however, is unlikely to be directly involved in stimulating SAA3 expression by TNF or other cytokines.
A recent study found that human SAA3, originally identified as a pseudogene, is expressed in the human mammary gland, and that expression of SAA3 is induced by prolactin (PRL) or lipopolysaccharide (LPS) in human mammary epithelial cells. 44) The promoter region of human SAA3 contains putative STAT3 (TTC-CCGGAA) and STAT5-like (TTCCCGGAA) binding sites positioned 1,607 basepairs (bp) and 429 bp upstream of the 5'UTR respectively. These cis-acting elements have been implicated in the up-regulation of SAA3 transcription following LPS or PRL stimulation. PRL-induced activation of STAT5 in human mammary epithelial cell lines has been demonstrated. 44, 45) IL-6 activates the JAK/STAT pathway in human mammary epithelial cells, 44, 46) but the influence of TNF on the activation of STAT factors in human mammary epithelial cells is currently unknown. Bing et al., however, reported that NFB was involved in the regulation of SAA3 promoter activity during cytokine-mediated induction in HepG2 cells. 47) This apparent discrepancy might be due to cell-specific differences in signaling pathways and transcription factors. Hence the involvement of alternate signaling pathways, in addition to NFB activation, in the up-regulation of SAA3 expression by TNF and other cytokines warrants further study. Among the molecules implicated in the regulation of SAA3 expression, NF1, Oct-1, AP-1, STAT3, and STAT5 also appear to be involved in the apoptosis of mammary epithelial cells. 38, 46) Although the precise biological functions of the SAA proteins has not been determined, several studies suggest that the N-terminal region of the various SAA isoforms is in part responsible for their structural and functional properties. The Nterminal region of SAA1 and SAA2 specifically binds to and transports cholesterol into HepG2 and aortic smooth muscle cells, indicating a possible role of A-SAA1 and A-SAA2 in the modulation of cholesterol flux during an acute phase response, as well as in atherosclerosis. 44, 48) Other studies indicate that the N-terminal region of A-SAA is the precursor for amyloid A, a chief constituent of amyloid fibrils found in secondary amyloidosis. 48) Recently, Larson et al. isolated the SAA3 isoform from the colostrum of several mammals, 44) and found that pretreatment of human intestinal epithelial cells with a synthetic peptide consisting of the N-terminal 10 amino acids of M-SAA3 stimulates production of the protective intestinal mucin MUC3 and significantly reduces enteropathogenic Escherichia coli (EPEC) adherence. 44) More recently, SAA was reported to induce IL-8 secretion and to inhibit platelet aggregation. SAA levels are closely related to chronic inflammatory 33) and coronary artery diseases. 34) SAA functions pathologically as a precursor of amyloid A (AA) protein in AA (secondary) amyloidosis, a serious complication of chronic inflammatory diseases such as rheumatoid arthritis (RA), juvenile inflammatory arthritis, and Castleman disease. 33) In the current study, our results suggest that overexpression of SAAs in HC11 cells accelerates apoptosis by enhancing caspase activity. Caspases are a family of proteases involved in proteolytic cleavage of cellular proteins during apoptosis, and many studies have shown that apoptosis is accompanied by the activation of specific caspases. 49 ) Caspases 3 and 7 are effector caspases, and their activation by upstream apical or initiator caspases (such as caspase 8) is one of the final events before cell death. 50) The results of the current study suggest that TNF-induced apoptosis of HC11 cells is mediated by increased expression of SAAs, since overexpression of SAAs accelerated the apoptosis of HC11 cells under SFM conditions and the effect of TNF-mediated apoptosis was not further enhanced in SAA overexpressing HC11 cells.
In summary, we found that overexpression of SAA1, SAA2, and SAA3 suppresses the growth of mammary epithelial cells under GM conditions and accelerates apoptosis through the activation of caspase activity under serum starvation conditions. Furthermore, induction of apoptosis in SAA-overexpressing HC11 cells was not further enhanced by TNF treatment, suggesting that TNF-mediated induction of apoptosis is mediated through induction of the expression of SAA isoforms. Additional studies are needed to identify the molecular components of the apoptotic pathway induced by overexpression of SAA genes.
